LONG GROVE PHARMACEUTICALS
News & Events
LONG GROVE PHARMACEUTICALS
News & Events
View Our Latest News and
See Our Schedule of Events Below
Upcoming Events
| Conference Dates | Details |
|---|---|
| August 19-22, 2024 | NPPA |
| August 22-24, 2024 | PSW Annual Meeting |
| August 26-28, 2024 | IDN Reverse Summit |
| September 12-14, 2024 | ICHP Annual Meeting |
| September 16-20, 2024 | Vizient Connections Summit |
| September 21, 2024, 2024 | Champions for Change Gala |
| September 25-28, 2024 | PSHP Annual Assembly |
In the News
Premix Norepinephrine
June 12, 2024
Long Grove Pharmaceuticals Launches Premix Norepinephrine
AK-FLUOR® Fluorescein Injection, USP
November 16, 2023
Fluorescein Injection Available While Long Grove Pharmaceuticals Takes Over Manufacture
Premix Norepinephrine Bitartrate in 0.9% Sodium Chloride
May 10, 2023
Long Grove Pharmaceuticals Secures Commercial Rights to Essential Critical Care Medication
Carboprost Tromethamine Injection, USP
January 12, 2023
Long Grove intros single-pack for generic Hemabate
Carboprost Tromethamine Injection, USP
January 12, 2023
Long Grove intros single-pack for generic Hemabate
Carboprost Tromethamine Injection, USP
January 10, 2023
Long Grove Pharmaceuticals Launches Single Pack for Carboprost Tromethamine Injection, USP
Carboprost Tromethamine Injection, USP
November 2, 2022
Long Grove Pharmaceuticals Launches Carboprost Tromethamine Injection, USP
Triamcinolone Acetonide
July 20, 2022
Long Grove launches first generic in US market
Triamcinolone Acetonide
July 26, 2022
Long Grove Pharma launches generic Kenalog-40
Triamcinolone Acetonide
July 19, 2022
Long Grove Pharma Launches Triamcinolone Acetonide Injectable Suspension, USP
Triamcinolone Acetonide
May 16, 2022
Long Grove Enters Specialized Generics Market
Long Grove Pharma
April 22, 2022
Long Grove Pharma set to be a new leader in specialized generics
Long Grove Pharma
April 19, 2022
Long Grove Pharmaceuticals to intro generics products
Press Releases
July | 2024
Long Grove Pharmaceuticals Receives FDA Approval for Generic Eribulin Mesylate Injection
May | 2024
Long Grove Pharmaceuticals Receives FDA Approval for Generic Edaravone Injection
May | 2024
Long Grove will soon offer Premix Vasopressin to help relieve stress on critical care
December | 2023
Long Grove Pharmaceuticals Launches Chemotherapy Medication in Partnership with Sunny Pharmtech
May | 2023
Long Grove Pharmaceuticals Secures Commercial Rights to Premix Norepinephrine in 0.9% Sodium Chloride
January | 2023
Long Grove Pharmaceuticals Launches First and Only Single-Pack Presentation for Carboprost Tromethamine Injection, USP
November | 2022
Long Grove Pharmaceuticals Launches Carboprost Tromethamine Injection, USP
July | 2024
Long Grove Pharmaceuticals Receives FDA Approval for Generic Eribulin Mesylate Injection
May | 2024
Long Grove Pharmaceuticals Receives FDA Approval for Generic Edaravone Injection
May | 2024
Long Grove will soon offer Premix Vasopressin to help relieve stress on critical care
December | 2023
Long Grove Pharmaceuticals Launches Chemotherapy Medication in Partnership with Sunny Pharmtech
May | 2023
Long Grove Pharmaceuticals Secures Commercial Rights to Premix Norepinephrine in 0.9% Sodium Chloride
January | 2023
Long Grove Pharmaceuticals Launches First and Only Single-Pack Presentation for Carboprost Tromethamine Injection, USP
July | 2022
Long Grove Pharmaceuticals Launches Triamcinolone Acetonide Injectable Suspension, USP
April | 2022
Long Grove Pharmaceuticals® Launches as New Leader in Specialized Generics
